Westfield Capital Management Co. LP purchased a new position in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) during the third quarter, HoldingsChannel reports. The fund purchased 1,003,916 shares of the company’s stock, valued at approximately $51,180,000. Other institutional investors and hedge funds have also modified their holdings of the company. Jennison Associates LLC grew its holdings […]
Rathbones Group PLC acquired a new stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 4,330 shares of the company’s stock, valued at approximately $221,000. Other hedge funds and other institutional investors have also […]
Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) has earned an average recommendation of “Buy” from the six brokerages that are presently covering the stock, Marketbeat.com reports. Six analysts have rated the stock with a buy recommendation. The average 1 year price objective among brokers that have updated their coverage on the stock in the last […]
Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) Director Heath Lukatch sold 5,000 shares of the company’s stock in a transaction on Wednesday, January 31st. The shares were sold at an average price of $71.50, for a total transaction of $357,500.00. Following the completion of the sale, the director now directly owns 5,625 shares in the […]
Victory Capital Management Inc. cut its holdings in Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 6.8% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 430,949 shares of the company’s stock after selling 31,355 shares during the quarter. Victory Capital Management […]